Next Generation Sequencing Testing (NGS)

A Contract Award Notice
by NHS BLOOD AND TRANSPLANT

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
£407K
Sector
MISCELLANEOUS
Published
25 Jun 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Award Detail

1 SGS (Ellesmere Port)
  • Next Generation Sequencing Testing (NGS)
  • Reference: 1
  • Value: £407,200

CPV Codes

  • None found

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-0514f8
  • FTS 059773-2026

Domains